about
Statistical methods for analyzing tissue microarray data.The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databasesA measure of explained variation for event history data.Directly-observed intermittent therapy versus unsupervised daily regimen during the intensive phase of antituberculosis therapy in HIV infected patientsDynamic predictions and prospective accuracy in joint models for longitudinal and time-to-event data.The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy.E2F1 and KIAA0191 expression predicts breast cancer patient survivalC-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.Nomogram to predict ypN status after chemoradiation in patients with locally advanced rectal cancer.Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein.Development of a nomogram model predicting current bone scan positivity in patients treated with androgen-deprivation therapy for prostate cancer.V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials.I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score.Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study.A web-based prognostic tool for extremity and trunk wall soft tissue sarcomas and its external validation.Preoperative Neutrophil-to-Lymphocyte Ratio and Neutrophilia Are Independent Predictors of Recurrence in Patients with Localized Papillary Renal Cell Carcinoma.Development of a nomogram incorporating serum C-reactive protein level to predict overall survival of patients with advanced urothelial carcinoma and its evaluation by decision curve analysis.Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma.Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling.Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients.Chromatin changes predict recurrence after radical prostatectomy.Optimal Duration of Daily Antituberculosis Therapy before Switching to DOTS Intermittent Therapy to Reduce Mortality in HIV Infected Patients: A Duration-Response Analysis Using Restricted Cubic Splines.Montreal prognostic score: estimating survival of patients with non-small cell lung cancer using clinical biomarkersA gradient boosting algorithm for survival analysis via direct optimization of concordance indexRisk of bleeding with oral anticoagulants: an updated systematic review and performance analysis of clinical prediction rules.Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW).Updated postoperative nomogram incorporating the number of positive lymph nodes to predict disease recurrence following radical prostatectomy.Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients.Fine tuning of the Van Nuys prognostic index (VNPI) 2003 by integrating the genomic grade index (GGI): new tools for ductal carcinoma in situ (DCIS).CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia.The clinical outcome after coronary bypass surgery: a 30-year follow-up study.Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.Are commonly ordered lab tests useful screens for alcohol disorders in older male veterans receiving primary care?.Validation of the current prognostic models for nonmetastatic renal cell carcinoma after nephrectomy in Chinese population: a 15-year single center experience.Predictors of competing mortality in early breast cancer.Discrimination measures for survival outcomes: connection between the AUC and the predictiveness curve.Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy.The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database study.The persistence of depression score.Kattan postoperative nomogram for renal cell carcinoma: predictive accuracy in a Japanese population.
P2860
Q33207692-BF42DA01-E526-4F0A-9E16-F57760CCE044Q33516060-8098A329-28C7-4BFF-9481-CBE13BE6457CQ33771071-C5BF0781-FDAF-4136-9DA2-F0D7B76ACE14Q33809970-88D18761-888D-4A70-A3EB-116FBEE2AF73Q33816264-B69ECA29-05AD-489A-8718-D239AA5868BBQ33842065-B3A0AB8A-5497-471D-A886-71F79C375466Q33858905-249A0E99-456F-4778-A76E-69F1CFA4120FQ33877471-C468EBAF-271E-412C-A19D-D51254E2B051Q33918074-47E4546C-99E6-403E-8D53-202F75AE729DQ34363552-CDDA641D-025B-4F06-88D2-8C3C2FCECE3AQ34406622-328B2965-3D8F-4E25-9578-ECEDCE04DAE3Q34733478-E19CA6CF-744B-4C0C-B9AE-6AC2FFC89138Q35208826-76C51091-FA09-4C5F-8A64-005FAE58BC7FQ35262855-A3926A5D-E7E7-4EFC-8453-615F4D3876EAQ35832325-DB21D857-0D19-49CD-BB8A-6B1DE785F54CQ36070506-C671D445-7D68-4BF8-8963-2FEE6D469AAEQ36287943-AD52BAF0-3ADC-4475-90F0-81E69D66F9AFQ36287965-E0AD0871-4BE1-4AE5-B292-A6102B5F4986Q36419132-2D15971D-49CB-45A3-889B-5C4A97D9B1FBQ36663605-80E0447C-29E8-4DEE-8272-A559663BA0EEQ36964361-86182711-B3A6-4900-93DA-C3944CEFC375Q36979305-CE80DB08-D390-40D6-B6D8-9480D3F156B2Q37235500-7E711E63-9A81-49A0-9993-91D6CA42296DQ37368389-C89FAC22-1862-47B0-BB01-FAD1EBE84166Q37889152-3E05D4AE-972D-4C00-82DA-FBFA98E27A05Q38206066-4842E9FE-8047-4C08-BDFA-6065454E30CAQ39105991-6E7589EC-A3D6-458D-A9BA-C82A9B292FB5Q39734908-F388F508-BF92-4191-9985-67200F396ADAQ39742231-F3B3D868-45C9-4123-814E-4E5EAB000613Q40784167-F7199528-A4C5-4A61-846F-910F6A30B357Q43637499-FA9AD8F3-B12B-4AC5-8CA9-C0103AD67900Q44509453-F2FD5F03-910B-4F1B-A253-92D31381A742Q45332757-51964FCB-4C41-4711-AA70-9538C45B7D77Q46495849-55AB6E84-01A8-4BFE-9AE6-34E21266E49EQ46559589-2CF06013-4CC2-4C48-B23A-FD21D3A99623Q48913600-13CFCECD-BC8F-46D5-B72A-0612C3655DEAQ50260314-9F273DF9-AEEA-4C8B-8E5D-77D1ABD1FABBQ51409536-60422331-BBB4-4AC4-BF82-29D805B45E99Q51910384-77B05D8A-E00B-459E-8A7B-3313AFCA563DQ53275907-9123E487-56EA-4052-B8DA-1D56FF2F35A8
P2860
description
article publié dans la revue scientifique Journal of the American Medical Association
@fr
im Mai 1982 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in The Journal of the American Medical Association
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 1982
@uk
name
Evaluating the yield of medical tests
@en
Evaluating the yield of medical tests
@nl
type
label
Evaluating the yield of medical tests
@en
Evaluating the yield of medical tests
@nl
prefLabel
Evaluating the yield of medical tests
@en
Evaluating the yield of medical tests
@nl
P356
P1476
Evaluating the yield of medical tests
@en
P2093
F. E. Harrell
P304
P356
10.1001/JAMA.247.18.2543
P407
P577
1982-05-14T00:00:00Z